[ad_1]
In response to the information that the Trump administration has hiked the value of recent H-1B visas from $2,000 – $5,000 to a whopping $100,000. MedCity Information Editor in Chief Arundhati Parmar talked concerning the deserves and challenges of this system generally and particularly for healthcare with Debunked Podcast co-host Samir Batra, managing associate of Well being Innovation Pitch.
“There are some legit considerations that employers have abused this technique, particularly with India, my nation of delivery, and have benefited tremendously,” Arundhati mentioned. “I agree with the criticism that this program has been abused….On the flip aspect, we don’t have sufficient folks with math and science abilities.”
Initially the main points of the visa program adjustments had been hazy, inflicting mass confusion as firms urged staff to chop brief their journey plans and return to the U.S. Expertise firms have used the H-1B visa to deal with a scarcity of pc science engineers throughout the U.S. Though the healthcare trade has relied on this system for many years to bolster nurse and doctor staffing, bringing professionals from Philippines and India, the numbers of H-1B visas issued in healthcare and medication symbolize a small fraction of the 141,205 complete new H-1B visas issued in fiscal yr 2024, in keeping with knowledge from the American Immigration Council.
One other subject raised within the newest version of Debunked was Bitcoin treasury firm Attempt’s acquisition of gadget firm Semlar Scientific. Semlar developed a check for peripheral artery illness and different continual situations. The mixed firm holds 10,900 BTC, making it the twelfth largest public bitcoin holder, in keeping with Cointelegraph. Samir shared insights on the implications for future M&A offers and the position bitcoin may play in these transactions. He additionally shared considerations that bitcoin risked inflating an organization’s worth based mostly on their digital property.
Misinformation round one reason behind autism, disseminated by the Trump administration, was extensively criticized final month. President Donald Trump and HHS Secretary Robert Kennedy Jr. named the energetic ingredient in Tylenol, acetaminophen, as a reason behind autism and urged pregnant ladies to not take the medicine, regardless of the dearth of conclusive proof for the claims. Physicians usually advocate pregnant ladies take Tylenol for ache or a excessive fever as a safer various to aspirin. Facilities for Medicare and Medicaid Companies Administrator Dr. Mehmet Oz contradicted his boss and downplayed considerations across the drug.
To take heed to the complete podcast, take a look at the video right here: Tylenol-Autism Misinformation | Debunked Ep. 20 | MedCity Information
[ad_2]
